In this interview, filmed at the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK), Simon Ellison, World Courier, explains more about the importance of considering the supply chain in the advanced therapy development process.
Cell therapy weekly: FDA files for permanent injunctions against two for-profit stem cell clinics
Cell therapy weekly: First-in-class clinical trial to investigate novel use for stem cell therapy
Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis
Developing a bioanalytical assay for stromal cell therapies: an interview with Laura Deedigan, Orbsen Therapeutics
Cell therapy weekly: Roche acquires MS program and GvHD therapy receives Orphan Drug Designation